The best indicator for Agilent Technologies (A)
We backtested 20 indicators across daily, weekly and hourly charts on real Agilent Technologies (A) history. Here's what actually worked — risk-adjusted, out-of-sample, with costs.
EMA 20/50 Cross
On the daily chart, this is the strongest risk-adjusted edge we found for Agilent Technologies (A) over ~26.5 years — beating buy-and-hold by 4.3% CAGR.
The winner on each chart
Every indicator, ranked
Ranked by Sharpe (risk-adjusted return). Hypothetical, fees included.
| # | Indicator | TF | CAGR | Sharpe | Max DD | Win | Trades | vs B&H |
|---|---|---|---|---|---|---|---|---|
| 1 | EMA 20/50 Cross ✓ | Daily | 10.7% | 0.53 | -51.0% | 38.2% | 55 | 4.3% |
| 2 | Donchian Breakout ✓ | Daily | 8.7% | 0.47 | -36.7% | 48.6% | 109 | 2.3% |
| 3 | Bollinger Mean-Reversion ✓ | Weekly | 5.0% | 0.39 | -59.2% | 85.0% | 20 | -1.7% |
| 4 | ADX / DMI | Daily | 5.7% | 0.36 | -61.5% | 37.8% | 164 | -0.7% |
| 5 | Rate of Change ✓ | Daily | 6.4% | 0.36 | -75.9% | 46.7% | 396 | 0.0% |
| 6 | Rate of Change ✓ | Weekly | 5.6% | 0.34 | -77.2% | 45.8% | 72 | -1.1% |
| 7 | MACD ✓ | Weekly | 5.2% | 0.33 | -70.4% | 48.1% | 54 | -1.5% |
| 8 | Donchian Midline ✓ | Daily | 5.3% | 0.32 | -82.6% | 41.0% | 344 | -1.1% |
| 9 | EMA-10 Trend ✓ | Weekly | 4.9% | 0.32 | -74.7% | 46.6% | 118 | -1.8% |
| 10 | EMA-10 Trend ✓ | Daily | 5.1% | 0.31 | -72.6% | 39.7% | 574 | -1.3% |
| 11 | Donchian Midline ✓ | Weekly | 4.2% | 0.3 | -59.2% | 42.9% | 70 | -2.5% |
| 12 | Bollinger Breakout ✓ | Daily | 4.0% | 0.29 | -55.6% | 44.7% | 123 | -2.4% |
| 13 | SMA 50/200 Cross ✓ | Daily | 3.7% | 0.28 | -55.4% | 52.4% | 21 | -2.7% |
| 14 | CCI ✓ | Weekly | 3.8% | 0.28 | -61.3% | 80.0% | 25 | -2.9% |
✓ = held up out-of-sample. Hypothetical, costs included. See methodology.
For Agilent Technologies (A), EMA 20/50 Cross on the daily timeframe gave the best balance of return and risk in our test. It beat buy-and-hold — but remember: this is a hypothetical backtest of a standard rule, not a recommendation. Markets change. See the methodology and disclaimer.
More stock
Get the weekly edge report
The best-performing indicator per asset, what changed this week, and the honest caveats — straight to your inbox.